Pediatrics


Showing 521-540 of 868 Results

  • Rishi Mediratta

    Rishi Mediratta

    Clinical Professor, Pediatrics

    Current Research and Scholarly InterestsI have developed a new promising neonatal mortality prediction score at the University of Gondar Neonatal Intensive Care Unit (NICU) in Gondar, Ethiopia. The score predicts approximately 84% of neonatal deaths in the NICU using clinical variables. I have a dataset over 800 NICU admissions in Gondar. I am recruiting scholars who are interested in conducting clinical and epidemiological research to validate, refine, and implement the mortality score to reduce neonatal mortality in Ethiopia.

  • Eric Meffre

    Eric Meffre

    Professor of Medicine (Immunology and Rheumatology)

    BioDr. Meffre obtained his PhD in Immunology from the Université d’Aix-Marseille in France before he moved to the USA as a postdoc fellow in the laboratory of Dr. Michel Nussenzweig at The Rockefeller University in New York City. He became an assistant professor at Cornell University in 2003 before being recruited at Yale University as associate professor in 2009. He was tenured at Yale in 2014 before he joined the Department of Medicine/Division of Immunology and Rheumatology at Stanford University as a tenured full professor in 2022.

    Dr. Meffre’s work focuses on the etiology of autoimmune syndromes and the roles played by B cells in these diseases. His group characterized the abnormal selection of developing autoreactive B cells in patients with rheumatoid arthritis (RA), systemic lupus erythematosus (SLE), type 1 diabetes (T1D), multiple sclerosis (MS) and Sjögren’s syndrome, resulting in large numbers of autoreactive naïve B cells accumulating in the patient’s blood. Hence, these autoreactive B cells may present self-antigens to T cells and initiate autoimmune diseases. These early B cell tolerance defects are likely primary to these autoimmune diseases and may result from genetic factors such as the 1858T PTPN22 allele that segregates with RA, SLE and T1D and correlate with an impaired removal of developing autoreactive B cells.
    His research goals also consist in characterizing the molecules and pathways involved in the establishment of B cell tolerance and the removal of developing autoreactive B cells generated by random V(D)J recombination through the investigation of rare patients with primary immunodeficiency (PID) enrolled through an international network. Alteration of B cell receptor (BCR) or Toll-like receptor (TLR) signaling in PID patients results in a defective central B cell tolerance and a failure to counterselect developing autoreactive B cells in the bone marrow. In contrast, functional and suppressive regulatory T cells play a key role in preventing the accumulation of autoreactive clones in the mature naïve B cell compartment. The recent development of humanized mouse models recapitulating early B cell tolerance checkpoints and their defects in autoimmune settings allow further in-depth investigation of tolerance mechanisms and the development of novel approaches to restore defective central and peripheral B cell tolerance checkpoints and thwart autoimmunity.

  • Kara Meister, MD, FAAP, FACS

    Kara Meister, MD, FAAP, FACS

    Assistant Professor of Otolaryngology - Head & Neck Surgery (OHNS) and, by courtesy, of Pediatrics

    BioKara D. Meister, MD, FAAP, FACS is a pediatric otolaryngologist and head & neck surgeon. She received her medical degree from Medical University of South Carolina and completed her otolaryngology residency at University of Pittsburgh. She completed a NIH-funded fellowship in head and neck research at the University of Pittsburgh. Dr. Meister then went on to complete a pediatric otolaryngology fellowship at Lucile Packard Children’s Hospital Stanford.

    She is currently an Assistant Professor in the Department Otolaryngology, Division of Pediatric Otolaryngology, at Stanford University. Dr. Meister’s research interests include thyroid cancer, head & neck masses, Graves' disease. She has a special interest in the influence of the environment and pollutants (such as microplastics) on health. She currently serves as the Clinical Chief of Pediatric Otolaryngology. Dr. Meister completed additional training in innovation through the Stanford Biodesign Faculty Fellowship.

    Her clinical interests include the treatment of patients with head and neck masses including thyroid nodules and cancer. She is the Surgical Director of the Children's Thyroid Clinic at Lucile Packard Children’s Hospital Stanford and is the Medical Director of the Tubes & Tonsils Surgery Clinic. She is co-editor of the textbooks "Pediatric Bronchoscopy for Clinicians" and "Atlas of Endoscopic Airway Surgery". She enjoys advocacy work with the American Academy of Pediatrics Button Battery Taskforce.

    Dr. Meister is a member of the American Thyroid Association (ATA) where she serves on the Diversity, Equity, and Inclusion committee and is a member of the ATA Guidelines Writing Group for Thyroid Disease & Pregnancy. She is a member of the pediatric committee of the American Head and Neck Society. She is an author and speaker on masses and tumors of the head and neck, thyroid disease, and thyroid cancer in children and adolescents. In collaboration with SHC, she offers novel treatment for thyroid problems in children and adolescents including radiofrequency ablation of thyroid nodules.

    Dr. Meister lives in Woodside with her husband, 3 children, and Rooney the dog.

    Clinical Expertise:
    Children's Thyroid Center, Co-Director, Surgical
    Thyroid nodules
    Thyroid cancer - papillary, follicular, and medullary
    Surgical management of hyperthyroidism and Grave's disease
    MEN syndrome
    Head and Neck masses
    Congenital neck masses such as branchial cleft cyst, thyroglossal duct cyst
    Pediatric Head and Neck cancer
    Airway evaluation and reconstruction, voice and swallowing problems, and Aerodigestive
    Fetal Airway and Exit Team

  • Elizabeth Mellins

    Elizabeth Mellins

    Member, Bio-X

    Current Research and Scholarly InterestsMolecular mechanisms and intracellular pathways of MHC class II antigen processing and presentation, with a focus on B cells; mechanisms underlying HLA allele association with disease; disease mechanisms in systemic juvenile idiopathic arthritis, including an HLA-linked complication; monocytes as drivers or suppressors of auto-inflammation in systemic juvenile idiopathic arthritis and pediatric acute neuropsychiatric syndrome.

  • Fernando S. Mendoza

    Fernando S. Mendoza

    Associate Dean of Minority Advising and Programs and Professor of Pediatrics (General Pediatrics) at the Lucile Salter Packard Children's Hospital, Emeritus

    Current Research and Scholarly InterestsI have two research interests: childhood health disparities and workforce diversity. My research on childhood health disparities centers on Latino and immigrant children with a focus on early childhood health and development. My work in workforce diversity examines the pipeline for diversity in academic pediatrics, with special attention on the pipeline for underrepresent minorities.

  • Bethel Roba Mieso

    Bethel Roba Mieso

    Clinical Assistant Professor, Pediatrics - General Pediatrics

    BioBethel R. Mieso, MD is a general pediatrician and clinical informatics fellow at Stanford Medicine whose work sits at the intersection of operational informatics, artificial intelligence ethics, pediatric care, and health equity. Dr. Mieso has played a key role in the enterprise-wide rollout of DAX Copilot at Stanford, leading ethical and regulatory guidance, trainee deployment, and patient-facing education. She has led a post-deployment evaluation of program director AI scribe policies across training programs, with findings informing strategic guidance for GME leaders nationwide–work that extends to her contributions to a national multi-institutional collaborative on AI in graduate medical education. Her research centers patient and family perspectives of ambient AI scribes in pediatric settings, shaping how health systems approach consent, communication, and trust with AI-assisted care.

    Dr. Mieso's work merges operational informatics with strategic AI implementation–streamlining clinical workflows, reducing provider burden, and ensuring that emerging technologies serve patients equitably. She holds a BS in Biology from San Jose State University, an MD from Case Western Reserve University School of Medicine, and completed her pediatrics residency at Stanford Medicine.

  • Carlos Milla

    Carlos Milla

    Professor of Pediatrics (Pulmonary Medicine) and, by courtesy, of Medicine (Pulmonary, Allergy and Critical Care Medicine)

    Current Research and Scholarly InterestsAt Stanford University I developed and currently direct the CF Translational Research Center. The overarching goal of the center is to provide the groundwork to streamline, accelerate, and promote the translation of basic discoveries into effective therapies and interventions to benefit patients affected by cystic fibrosis. My laboratory group currently has three main lines of investigation: respiratory cell biology in CF; remote biochemical monitoring; and lung physiology in young children.

  • Kevin Mintz

    Kevin Mintz

    Instructor, Pediatrics - Center for Biomedical Ethics

    Current Role at StanfordSocial Science Research Scholar (Stanford Center for Biomedical Ethics)

  • Maneesh Kumar Misra

    Maneesh Kumar Misra

    Clinical Associate Professor, Pathology

    Current Research and Scholarly InterestsMy research goal is to utilize the cutting edge of stat of art histocompatibility testing to better understand the humoral and cellular responses in clinical transplantation, and to translate this knowledge into improved treatment, and transplant outcome.

  • Daria Mochly-Rosen

    Daria Mochly-Rosen

    George D. Smith Professor of Translational Medicine

    Current Research and Scholarly InterestsTwo areas: 1. Using rationally-designed peptide inhibitors to study protein-protein interactions in cell signaling. Focus: protein kinase C in heart and large GTPases regulating mitochondrial dynamics in neurodegdenration. 2. Using small molecules (identified in a high throughput screens and synthetic chemistry) as activators and inhibitors of aldehyde dehydrogenases, a family of detoxifying enzymes, and glucose-6-phoshate dehydrogenase, in normal cells and in models of human diseases.

  • Michelle Monje

    Michelle Monje

    Milan Gambhir Professor of Pediatric Neuro-Oncology and Professor, by courtesy, of Neurosurgery, of Pediatrics, of Pathology and of Psychiatry and Behavioral Sciences

    Current Research and Scholarly InterestsThe Monje Lab studies the molecular and cellular mechanisms of postnatal neurodevelopment. This includes microenvironmental influences on neural precursor cell fate choice in normal neurodevelopment and in disease states.

  • Maren Monsen, MD

    Maren Monsen, MD

    Sr Research Scholar, Pediatrics - Center for Biomedical Ethics

    Current Research and Scholarly InterestsMaren Monsen, MD has directed multiple documentary films that have been nominated for Emmy Awards, broadcast on PBS, translated into many languages for international broadcast, and used in 75% of medical schools across the country. Her films include The Revolutionary Optimists, Rare, Worlds Apart, Where the Highway Ends and The Vanishing Line. She is the founder and director the Program in Bioethics and Film at Stanford Center for Biomedical Ethics.

  • Stephen B. Montgomery

    Stephen B. Montgomery

    Stanford Medicine Professor of Pathology, Professor of Genetics and of Biomedical Data Science and, by courtesy, of Computer Science

    Current Research and Scholarly InterestsWe focus on understanding the effects of genome variation on cellular phenotypes and cellular modeling of disease through genomic approaches such as next generation RNA sequencing in combination with developing and utilizing state-of-the-art bioinformatics and statistical genetics approaches. See our website at http://montgomerylab.stanford.edu/